Novartis Investigative Site

Santiago de Surco, Lima region 33

0 studies enrolling now · 5 studies all time

What they study most

Ankylosing Spondylitis, Asthma, Cardiovascular Disease, Chronic Obstructive Pulmonary Disease, Lupus Nephritis, Type 2 Diabetes Mellitus

Studies at this site

• Study of Safety, Efficacy and Tolerability of Secukinumab Versus Placebo, in Combination With SoC Therapy, in Patients With Active Lupus Nephritis — Stopped early
• Effect of Secukinumab on Radiographic Progression in Ankylosing Spondylitis as Compared to GP2017 (Adalimumab Biosimilar) — Completed
• Dose Finding Study for QAW039 in Asthma — Completed
• Aliskiren Trial in Type 2 Diabetes Using Cardiovascular and Renal Disease Endpoints (Core and Extension Phases) — Stopped early
• Effect of QVA149 Versus NVA237 and Tiotropium on Chronic Obstructive Pulmonary Disorder (COPD) Exacerbations — Completed